Glaucoma Open-angle
📧 Sign up to get email alerts when something new happens for Glaucoma Open-angle.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) [NA]
The clinical trial update indicates termination of the Trident study evaluating the OMNI Surgical System and iStent for open-angle glaucoma,…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2) [NA]
The SAFARI 2 trial evaluating a novel interposition supraciliary implant for open-angle glaucoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 trial comparing Perrigo's glaucoma/ocular hypertension product to an FDA-approved comparator has completed, and results have been po…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Performance of the Travoprost Intraocular Implant [Phase 2]
Phase 2 trial results for the travoprost intraocular implant targeting open-angle glaucoma and ocular hypertension have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Lamina Cribrosa Depth Change With Change in Eye Pressure [NA]
A Johns Hopkins University–led clinical trial (NCT03267849) evaluating lamina cribrosa depth changes with intraocular pressure changes in op…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure? [Phase 4]
A Phase 4 trial evaluated whether reduced dosing of latanoprost and dorzolamide-timolol affects intraocular pressure in glaucoma, and the st…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of 2% citicoline eye drops for preserving the visual field in open-angle glaucoma is curren…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Use of Methazolamide to Lower Intraocular Pressure [Phase 4]
Phase 4 trial update on methazolamide to lower intraocular pressure in open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. [Phase 4]
Phase 4 trial comparing two PF-formulation eye drops for open-angle glaucoma and ocular hypertension; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Clinical Study Comparing Two Models of a Travoprost Intraocular Implant [Phase 3]
Phase 3 clinical study comparing two models of a travoprost intraocular implant in glaucoma and ocular hypertension completed with results p…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Glaucoma Surgery Using the ViaLase Laser System [NA]
Clinical trial update for glaucoma surgery using the ViaLase laser system; the study is completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma [Phase 3]
Phase 3 bioequivalence study with clinical endpoints comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN in chronic open-angle glauco…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma [NA]
Post-market study of the OMNI surgical system in open-angle glaucoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. [Phase 3]
Phase 3 bioequivalence study with clinical endpoint comparing bimatoprost ophthalmic solution 0.01% to LUMIGAN in chronic open-angle glaucom…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. [Phase 4]
Phase 4 trial assessing 24-hour efficacy and tolerability of tafluprost-timolol fixed combination without preservatives in glaucomatous or o…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma [NA]
Clinical trial update reporting outcomes of MicroPulse trans-scleral cyclophotocoagulation in uncontrolled glaucoma; study completed with re…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update on efficacy and safety of bimatoprost sustained-release (SR) in open-angle glaucoma and ocular hypertension; results po…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma [Phase 4]
Phase 4 clinical trial assessing how topical prostaglandins affect the corneal biomechanical properties in open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma [Phase 3]
A Phase 3 randomized, double-masked trial comparing evening dosing of Xalacom in glaucoma and ocular hypertension; the study is completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [Phase 3]
Phase 3 trial update for Xalacom and a fixed unfixed combination of latanoprost and timolol in open-angle glaucoma or ocular hypertension; t…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma [Phase 4]
Phase 4 trial assessing 3 months of latanoprost to reduce intraocular pressure in ocular hypertension or open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing [Phase 4]
Phase 4 trial comparing morning versus evening dosing of preservative-free Tafluprost/Timolol fixed combination for open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Assessment of Effectiveness Ex-Press Surgery Modification [NA]
A completed clinical trial assessing the effectiveness of a modification to Ex-PRESS glaucoma surgery.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of COMBIGAN in Korean patients with primary open-angle glaucoma and normal tension g…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Glaucoma Eye Drop Instillation: Impact of Education [NA]
A Northwestern University-sponsored trial evaluated the impact of patient education on glaucoma eye drop instillation in open-angle glaucoma…